SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001404644-24-000067
Filing Date
2024-06-17
Accepted
2024-06-17 14:35:37
Documents
1
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718649330.html 4  
1 FORM 4 wk-form4_1718649330.xml 4 4065
  Complete submission text file 0001404644-24-000067.txt   5780
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Issuer) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301
Business Address
Freedland Cory S. (Reporting) CIK: 0001832569 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36327 | Film No.: 241047790